The prothrombin G20210A mutation is most commonly seen in Europeans and is less prevalent in Asians, and patients with the 20210A allele have a relative risk of thrombosis of 2.8 (95% CI: 1.4 to 5.6)26. This evidence concerns the gene F2 and Venous thrombosis.